Photo taken from
Sarju Ganatra/X
Mar 27, 2024, 04:49
Sarju Ganatra: Cardiotoxity of CAR T-cell Therapy in Multiple Myeloma
Sarju Ganatra, Vice Chair at Lahey Hospital Department of Medicine Research, shared a post on X:
“Cardiotoxity of CAR T-cell Therapy in Multiple Myeloma
- CardioOncology IMS24 Boston
- 5 to 10% develop cardiomyopathy/heartfailure
- cardiotoxicity associated with adverse outcomes
- Pre CAR T cardiovascular work up & optimization and close monitoring post CART are crucial
- Early use of anti-IL-6 agenet
- Need larger and longer-term data to better understand lasting impact of immunomdulation on the cardiovascular system
Thank you Myeloma Society for the opportunity to present on this subject”
Source: Sarju Ganatra/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023